Moses Galukande

From IntactiWiki
Revision as of 13:21, 21 August 2022 by WikiAdmin (talk | contribs) (using Template:Population-based studies)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Moses Galukande is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]

Biography

The WHO published the following biography of Moses Galukande:

Galukande Moses

Moses Galukande, a specialist general surgeon in active surgical practice. He is also an academic and is Head of Surgery Department, School of Medicine College of Health Sciences at Makerere University in Kampala, which is Uganda’s oldest and largest university. He is a Director of Surgery, Education and Research for International Medical Group (IMG). IMG is a conglomerate comprised of a hospital, a health Insurance company, a pharmaceutical company and numerous clinics. He has contributed to HIV prevention control through delivery of Safe Male Circumcision (SMC) services. In collaboration with Infectious Disease Institute, at Makerere and other implementation partners supported by Centers for Disease Control and Prevention (CDC), he has directly supervised the conduct of over 48,000 SMCs since 2011.

He has participated in several SMC related research and published several papers in the area. He is a member of the SMC safety monitoring team for the Ministry of Health, Uganda, as well as being a member of the WHO Technical Advisory Group on Innovations in Male Circumcision from 2014. Professor Galukande has authored over 110 papers in peer reviewed journals; he has worked both in the private and public health service delivery systems. He is also a medical education expert with special interest in curriculum development, evaluation and assessment for quality of Medical education. He sits on several education and health service advisory committees.[2]

Dr. Gaulukande was the lead autor of an article to report on the outcome of circumcision surgery with the PrePex circumcision device.[3] He reported favorably. It appears that he favors circumcision.

Population-based studies

September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:

  1. Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[4]
  2. Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[5]

No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.

See also

• Bias

Abbreviations

  1. ↑ REFweb Bachelor of Medicine, Bachelor of Surgery, Wikipedia. Retrieved 13 October 2021. (Latin: medicinae baccalaureus, baccalaureus chirurgiae; abbreviated in many ways, most commonly MBBS, but also MB ChB, BMBS, MB BCh, MB BChir, and BM BCh.)
  2. ↑ REFweb Master of Science, Wikipedia. Retrieved 13 October 2021. (Latin: magisterii scientiae; also abbreviated MS, MSc, M.Sc., SM, S.M., ScM or Sc.M.)
  3. ↑ REFweb Doctor of Philosophy, Wikipedia. Retrieved 16 June 2021. (Also abbreviated as D.Phil.)

References

  1. ↑ REFweb (May 2018). WHO to develop new guidelines on male circumcision. Retrieved 26 March 2020.
  2. ↑ REFdocument Biographies of Guideline Development Group (GDG) members for WHO guidance PDF, WHO. (September 2018). Retrieved 26 March 2020.
  3. ↑ REFjournal Gaulukande M, et al. Long term post PrePex male circumcision outcomes in an urban population in Uganda: a cohort study.. BMC Res Notes. 30 October 2017; 10(1): 522. PMID. PMC. DOI. Retrieved 3 April 2020.
  4. ↑ REFjournal Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
    Quote: We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
  5. ↑ REFjournal Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
Retrieved from "https://en.intactiwiki.org/w/index.php?title=Moses_Galukande&oldid=29629"